Amit Gupta - 16 Aug 2026 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: CDLX
Reported as of: 16 Aug 2026
Net transaction value: -$53,820
SEC form: 4
Accepted by SEC: 18 Aug 2026, 17:27:23 UTC
Prior SEC filing: 06 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Chris Cheng, Attorney-in-Fact

Key filing fact

Amit Gupta filed Form 4 for Cardlytics, Inc. (CDLX) on 18 Aug 2026.

Key facts

This page summarizes Amit Gupta's Form 4 filing for Cardlytics, Inc. (CDLX).
6 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 18 Aug 2026, 17:27.

Change

Previous filing in this sequence was filed on 06 Jul 2026.
Current net transaction value: -$53,820.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001961238 Primary reporting owner

Gupta Amit

Relationship: Chief Executive Officer, Director
Address: 675 PONCE DE LEON AVENUE NE, SUITE 4100, ATLANTA
Signature: /s/ Chris Cheng, Attorney-in-Fact
Signature date: 18 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CDLX transaction

Common Stock

Options Exercise

Transaction value
Shares: +12,500
Change %: +11%
Price
Shares after: 126,350
Date: 16 Aug 2026
Ownership: Direct
Footnotes: F1

CDLX transaction

Common Stock

Options Exercise

Transaction value
Shares: +12,500
Change %: +9.9%
Price
Shares after: 138,850
Date: 16 Aug 2026
Ownership: Direct
Footnotes: F1

CDLX transaction

Common Stock

Sale

Transaction value: $26,909
Shares: -6,785
Change %: -4.9%
Price: $3.97
Shares after: 132,065
Date: 17 Aug 2026
Ownership: Direct
Footnotes: F2

CDLX transaction

Common Stock

Sale

Transaction value: $26,911
Shares: -6,676
Change %: -5.1%
Price: $4.03
Shares after: 125,389
Date: 18 Aug 2026
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CDLX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -12,500
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 16 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,500
Exercise price
Footnotes: F1, F4

CDLX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -12,500
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 16 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,500
Exercise price
Footnotes: F1, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

Footnote F2

The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $3.860 to $4.150, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2).

Footnote F3

The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $4.000 to $4.105, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).

Footnote F4

The RSU award is for 50,000 shares that were granted on August 21, 2024. The RSUs will vest and have vested in four installments over a period of 24 months following August 16, 2024, the date the Reporting Person assumed the role of Chief Executive Officer, with 25% of the RSUs vesting on each of the six-, twelve-, eighteen- and twenty-four-month anniversaries, provided that the Reporting Person remains employed by the Issuer on such vesting date.

Footnote F5

The RSU award is for 50,000 shares that were granted on January 29, 2025. The RSUs will vest in four installments over a period of 24 months following August 16, 2024, the date the Reporting Person assumed the role of Chief Executive Officer, with 25% of the RSUs vesting on each of the six-, twelve-, eighteen- and twenty-four-month anniversaries, provided that the Reporting Person remains employed by the Issuer on such vesting date.

SEC remarks

Exhibit List - Exhibit 24 - Power of Attorney